What are the ECG criteria for left bundle‑branch block (LBBB) and how should a newly discovered LBBB be evaluated and managed?

Left Bundle Branch Block (LBBB): ECG Criteria and Clinical Management

ECG Diagnostic Criteria

The standard ECG criteria for LBBB require QRS duration ≥120 ms in adults with specific morphologic features, though newer refined criteria improve diagnostic accuracy for true conduction block. 1

Core Diagnostic Features

• QRS duration ≥140 ms in men or ≥130 ms in women represents the stricter threshold that better identifies true LBBB 2
• QS or rS pattern in leads V1 and V2 is required to demonstrate the characteristic septal activation abnormality 2
• Mid-QRS notching or slurring in ≥2 lateral leads (V1, V2, V5, V6, I, and aVL) reflects the delayed and fragmented left ventricular activation 2

Enhanced Specificity Criterion

• Time to notch >75 ms in lead I, when used alongside standard LBBB criteria, significantly improves specificity (74% vs 33% for older criteria) while maintaining 71% sensitivity for identifying true complete conduction block 3
• This simple measurement helps distinguish true LBBB from intraventricular conduction delay (IVCD), which has important implications for cardiac resynchronization therapy candidacy 3

Clinical Evaluation of Newly Discovered LBBB

When LBBB is newly identified, immediate assessment must focus on excluding acute myocardial infarction, evaluating for structural heart disease, and determining the risk of progression to complete heart block.

Acute Presentation: Rule Out MI

• Most patients (70%) with chest pain and LBBB do NOT have acute MI, making accurate diagnosis critical 4
• ECG criteria alone have very low sensitivity (1-12%) but high specificity (95-100%) for detecting MI in the presence of LBBB 4
• High-sensitivity cardiac troponin at 0 and 1-hour (or 2-hour) intervals provides excellent diagnostic accuracy (AUC 0.89-0.91) and should be the primary diagnostic tool 4
• The distinction between "new" versus "old" LBBB has limited clinical utility—both groups have similar MI rates (29% vs 35%) 4

Risk Stratification for Conduction System Disease

• Assess for symptoms of bradycardia: syncope, presyncope, dizziness, or heart failure symptoms that may indicate progression toward complete AV block 1
• Evaluate for bifascicular block patterns: when LBBB occurs with marked axis deviation or in combination with right bundle branch block, the risk of complete heart block increases substantially 1
• Screen for reversible causes: review medications (beta-blockers, calcium channel blockers, antiarrhythmics), assess for sleep apnea, and check thyroid function 1

Diagnostic Testing Algorithm

• Continuous cardiac monitoring (inpatient telemetry or ambulatory Holter) to detect pauses, higher-grade AV block, or progression to complete heart block 1
• Transthoracic echocardiography to evaluate left ventricular ejection fraction, wall motion abnormalities, and structural heart disease 1
• Advanced cardiac imaging (cardiac MRI, PET, or CT) when infiltrative diseases such as sarcoidosis or amyloidosis are suspected based on clinical context 1

Management and Prognosis

Pacemaker Indications

• Class I indication: Permanent pacemaker is indicated when symptoms clearly attributable to bradycardia (syncope, presyncope, heart failure symptoms, cognitive impairment) are documented with LBBB, particularly in the setting of bifascicular block 1
• Class IIa indication: Pacemaker is reasonable for unexplained syncope with bifascicular block even without documented complete AV block 1

Long-Term Outcomes

• Newly acquired LBBB in STEMI patients carries significantly worse prognosis with higher rates of mortality (HR 2.15), reinfarction, and need for revascularization over long-term follow-up 5
• New LBBB after transcatheter aortic valve replacement (TAVR) increases 1-year mortality by 19% (adjusted HR 1.19), hospital readmission by 23%, and permanent pacemaker requirement by 3.5-fold 6
• Patients with multifocal conduction disease (LBBB plus sinus node dysfunction) have substantial likelihood of progressing to complete AV block and warrant close surveillance 1

Common Pitfalls

• Avoid assuming all LBBB with chest pain represents MI—troponin testing is essential as ECG criteria perform poorly 4
• Do not dismiss LBBB as benign—it independently predicts adverse outcomes and warrants thorough evaluation for underlying structural disease 5
• Recognize that lower LVEF and longer symptom-to-treatment time compound the risk associated with LBBB, making timely intervention critical 5